Keros Therapeutics, Inc. (KROS): 10-Q filed Nov 5, 2026

Form type
10-Q
Filing date
Nov 5, 2026
Accession number
0001664710-26-000066
Filer
Keros Therapeutics, Inc. (CIK 1664710)